Are selective COX 2 inhibitors superior to traditional n... [BMJ. 2002] - PubMed

Review [Clinical use of COX-2 inhibitors]. [Vojnosanit Pregl. 2001]
Review [Clinical use of COX-2 inhibitors].
Ristić GG, Stefanović DZ. Vojnosanit Pregl. 2001 May-Jun; 58(3):283-95.
Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis. [Ann Intern Med. 2003]
Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
. Ann Intern Med. 2003 May 20; 138(10):I39.
COX-2 inhibitors. Magic bullets or merely mortal? [Harv Health Lett. 2000]
COX-2 inhibitors. Magic bullets or merely mortal?
. Harv Health Lett. 2000 Feb; 25(4):4.
COX-2 inhibitors: new drugs for the management of pain and inflammation. [Dent Today. 2001]
COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V, Hutchins B. Dent Today. 2001 Feb; 20(2):56-61.
Review What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. [Clin Exp Rheumatol. 2001]
Review What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC. Clin Exp Rheumatol. 2001 Nov-Dec; 19(6 Suppl 25):S15-22.

Why we need easy access to all data from all clinical trials and how to accomplish it. [Trials. 2011]
Why we need easy access to all data from all clinical trials and how to accomplish it.
Gøtzsche PC. Trials. 2011 Nov 23; 12:249. Epub 2011 Nov 23.
cPLA2 is protective against COX inhibitor-induced intestinal damage. [Toxicol Sci. 2010]
cPLA2 is protective against COX inhibitor-induced intestinal damage.
Montrose DC, Kadaveru K, Ilsley JN, Root SH, Rajan TV, Ramesh M, Nichols FC, Liang BT, Sonin D, Hand AR, et al. Toxicol Sci. 2010 Sep; 117(1):122-32. Epub 2010 Jun 18.
Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study. [Br J Clin Pharmacol. 2009]
Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study.
Wheeler BW, Metcalfe C, Gunnell D, Stephens P, Martin RM. Br J Clin Pharmacol. 2009 Nov; 68(5):752-64.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflam...
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
BMJ. 2002 Jun 1 ;324(7349):1287-8.

PubMed
Variability in synovial inflammation in rheumatoid arthritis investigated by mic...
Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology.
Arthritis Res Ther. 2006 ;8(2):R47. Epub 2006 Feb 16 .

PubMed
Conservative correction of leg-length discrepancies of 10mm or less for the reli...
Conservative correction of leg-length discrepancies of 10mm or less for the relief of chronic low back pain.
Arch Phys Med Rehabil. 2005 Nov ;86(11):2075-80.

PubMed
Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid a...
Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
Arthritis Rheum. 2005 Jul ;52(7):1993-8.

PubMed
Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage.
Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage.
Arthritis Res Ther. 2005 ;7(2):R274-84. Epub 2005 Jan 11 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed